Kiniksa Pharmaceuticals
KNSA
KNSA
52 hedge funds and large institutions have $385M invested in Kiniksa Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
12.36% less ownership
Funds ownership: 91.5% → 79.15% (-12%)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.9M | |
| 2 | +$5.46M | |
| 3 | +$1.88M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.25M |
| 5 |
SIM
Spark Investment Management
New York
|
+$561K |
Top Sellers
| 1 | -$35.4M | |
| 2 | -$26.5M | |
| 3 | -$24.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.9M |
| 5 |
Millennium Management
New York
|
-$3.25M |